Genomic analysis to identify correlates of the inflamed tumor phenotype in patients with advanced malignancies receiving immunotherapy
RNA-seq (gene expression) · human · 41 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 41 samples: 28 × YZHA vs 13 × YZGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting the novel immune checkpoint KLRG1 is markedly therapeutic against cancer through multiple lymphocyte subsetsJournal for immunotherapy of cancer · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE319884_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1425476 and SRA study SRP678026. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 41 samples.
How we read this: 2 replicated groups read from 41 sample titles; they account for 41 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9528582 YZ-008 YZ
- GSM9528583 YZ-155 YZ
- GSM9528584 YZ-156 YZ
- GSM9528585 YZ-158 YZ
- GSM9528586 YZ-162 YZ
- GSM9528587 YZ-169 YZ
- GSM9528588 YZ-17 YZ
- GSM9528589 YZ-174 YZ
- GSM9528590 YZ-183 YZ
- GSM9528591 YZ-187 YZ
- GSM9528592 YZ-202 YZ
- GSM9528593 YZ-212 YZ
- GSM9528594 YZ-225 YZ
- GSM9528595 YZHA-262 YZHA
- GSM9528596 YZHA-288 YZHA
- GSM9528597 YZHA-290 YZHA
- GSM9528598 YZHA-291 YZHA
- GSM9528599 YZHA-292 YZHA
- GSM9528600 YZHA-293 YZHA
- GSM9528601 YZHA-294 YZHA
- GSM9528602 YZHA-295 YZHA
- GSM9528603 YZHA-296 YZHA
- GSM9528604 YZHA-297 YZHA
- GSM9528605 YZHA-298 YZHA
- GSM9528606 YZHA-299 YZHA
- GSM9528607 YZHA-300 YZHA
- GSM9528608 YZHA-301 YZHA
- GSM9528609 YZHA-302 YZHA
- GSM9528610 YZHA-304 YZHA
- GSM9528611 YZHA-305 YZHA
- GSM9528612 YZHA-306 YZHA
- GSM9528613 YZHA-307 YZHA
- GSM9528614 YZHA-308 YZHA
- GSM9528615 YZHA-480 YZHA
- GSM9528616 YZHA-481 YZHA
- GSM9528617 YZHA-482 YZHA
- GSM9528618 YZHA-487 YZHA
- GSM9528619 YZHA-489 YZHA
- GSM9528620 YZHA-498 YZHA
- GSM9528621 YZHA-500 YZHA
+ 1 more — browse all 41 samples with per-sample file links →
- GSE310672 Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation [RNA-seq] 48 samples shares phenotype, advanced
- GSE311200 Comprehensive analysis of the correlation between circulating biomarkers and tumor-immune microenvironment in advanced or recurrence non-small cell lung cancer in various treatment options, i.e., immunotherapy, EGFR TKI, and chemotherapy 41 samples shares immunotherapy, advanced
- GSE315928 Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer [paired scRNA/TCR-seq] 94 samples shares immunotherapy, advanced
- GSE264741 Functional Screening and Transcriptomic Analysis Identify Novel Druggable Dependencies and Immunotherapy Targets in Desmoplastic Small Round Cell Tumor 124 samples shares immunotherapy
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples shares immunotherapy
- GSE312235 Tumors Hijack Immune-Privileging Regulons via Distinct Cell Types to Confer T Cell Desertion and Immunotherapy Resistance Across Various Cancers 72 samples shares immunotherapy
- GSE296954 Differentiation of tumor-infiltrating GZMK+ effector memory T cells associates with response to neoadjuvant immunotherapy in head and neck cancer 44 samples shares immunotherapy
- GSE242299 Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype 31 samples shares phenotype
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.